- Home
- INTS vs XBP Comparison
INTS vs XBP Comparison
Compare INTS & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- XBP
- Stock Information
- Founded
- INTS 2012
- XBP 2020
- Country
- INTS United States
- XBP United States
- Employees
- INTS N/A
- XBP N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- XBP Business Services
- Sector
- INTS Health Care
- XBP Consumer Discretionary
- Exchange
- INTS Nasdaq
- XBP Nasdaq
- Market Cap
- INTS 10.9M
- XBP 71.0M
- IPO Year
- INTS 2023
- XBP N/A
- Fundamental
- Price
- INTS $0.24
- XBP $1.00
- Analyst Decision
- INTS Strong Buy
- XBP
- Analyst Count
- INTS 4
- XBP 0
- Target Price
- INTS $4.50
- XBP N/A
- AVG Volume (30 Days)
- INTS 4.2M
- XBP 392.1K
- Earning Date
- INTS 11-12-2025
- XBP 11-11-2025
- Dividend Yield
- INTS N/A
- XBP N/A
- EPS Growth
- INTS N/A
- XBP N/A
- EPS
- INTS N/A
- XBP N/A
- Revenue
- INTS N/A
- XBP $148,332,000.00
- Revenue This Year
- INTS N/A
- XBP N/A
- Revenue Next Year
- INTS N/A
- XBP N/A
- P/E Ratio
- INTS N/A
- XBP N/A
- Revenue Growth
- INTS N/A
- XBP 0.23
- 52 Week Low
- INTS $0.19
- XBP $0.42
- 52 Week High
- INTS $4.19
- XBP $2.56
- Technical
- Relative Strength Index (RSI)
- INTS 37.27
- XBP 67.74
- Support Level
- INTS $0.22
- XBP $0.80
- Resistance Level
- INTS $0.30
- XBP $1.04
- Average True Range (ATR)
- INTS 0.02
- XBP 0.10
- MACD
- INTS -0.00
- XBP 0.05
- Stochastic Oscillator
- INTS 29.21
- XBP 91.34
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About XBP XBP Europe Holdings Inc.
XBP Global Holdings Inc is a multinational leader in business process automation, serving over 2,500 clients-including more than 30 Fortune 100 companies. Its proprietary software and deep domain expertise position it as a trusted technology and services partner. With cloud-based solutions and a global footprint, XBP Global delivers measurable value, improves advances digital transformation, improves market-wide liquidity by expediting payments, and promotes sustainable business practices.